Lodewyk F.A. Wessels

Active 1992–2025

Also published as
Lodewyk F. A. Wessels
205
Papers
42,759
Citations
90
h-index
177
i10-index

Citations

Citations per year for Lodewyk F.A. Wessels1976: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1993: 2 citations1994: 6 citations1995: 8 citations1996: 6 citations1997: 4 citations1998: 14 citations1999: 9 citations2000: 12 citations2001: 15 citations2002: 16 citations2003: 28 citations2004: 36 citations2005: 64 citations2006: 93 citations2007: 149 citations2008: 214 citations2009: 230 citations2010: 271 citations2011: 306 citations2012: 300 citations2013: 421 citations2014: 398 citations2015: 489 citations2016: 524 citations2017: 608 citations2018: 655 citations2019: 1,723 citations2020: 2,074 citations2021: 2,183 citations2022: 1,832 citations2023: 1,493 citations2024: 2,261 citations2025: 1,308 citations2026: 75 citations1977–1983: no citations, so these years are not shown1987–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,940 citing papers, 22% of this breakdownChina: 3,287 citing papers, 12.2% of this breakdownUnited Kingdom: 1,898 citing papers, 7% of this breakdownGermany: 1,612 citing papers, 6% of this breakdownNetherlands: 1,534 citing papers, 5.7% of this breakdownItaly: 1,187 citing papers, 4.4% of this breakdownFrance: 977 citing papers, 3.6% of this breakdownSpain: 861 citing papers, 3.2% of this breakdownCanada: 797 citing papers, 2.9% of this breakdownJapan: 686 citing papers, 2.5% of this breakdownAustralia: 665 citing papers, 2.5% of this breakdownSwitzerland: 592 citing papers, 2.2% of this breakdown
0%22%Other 25.8%

Fields

  • Biochemistry, Genetics and Molecular Biology46%
  • Medicine37.7%
  • Computer Science5.5%
  • Immunology and Microbiology4%
  • Engineering2.7%
  • Neuroscience1.1%
  • Other3%

Topics

  • Cancer Cells and Metastasis4.4%
  • Cancer Genomics and Diagnostics4.3%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Genomics and Chromatin Dynamics2.4%
  • Epigenetics and DNA Methylation2.3%
  • Bioinformatics and Genomic Networks2.2%
  • Other80.5%

Coauthors

All papers

Open in search
  1. The consensus molecular subtypes of colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René Bernards, Stephen Friend, Pierre Laurent‐Puig, Jan Paul Medema, Anguraj Sadanandam, Lodewyk F.A. Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar - Nature Medicine 2015 cited by 5,259

  2. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Clevers - Cell 2017 cited by 2,034

  3. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gad Getz, Lodewyk F.A. Wessels, Michael R. Stratton, Ultan McDermott, Matthew Meyerson, Mathew J. Garnett, Hans Clevers - Cell 2015 cited by 2,472

  4. A Landscape of Pharmacogenomic Interactions in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manel Esteller, Nathanael S. Gray, Daniel A. Haber, Michael R. Stratton, Cyril H. Benes, Lodewyk F.A. Wessels, Julio Sáez-Rodríguez, Ultan McDermott, Mathew J. Garnett - Cell 2016 cited by 2,304

  5. Effective drug combinations in breast, colon and pancreatic cancer cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 463

  6. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Ton N. Schumacher, Christian U. Blank, Marleen Kok - Nature Medicine 2019 cited by 889

  7. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 826

  8. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 392

  9. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 298

  10. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 498

  11. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions

    Authors: , , , , , , , , , , - Nature 2008 cited by 2,010

  12. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 473

  13. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 397

  14. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 207

  15. A pan-cancer analysis of the microbiome in metastatic cancer

    Authors: , , , , , , , , , , , , , , , , , - Cell 2024 cited by 205

  16. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 714

  17. Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 912

  18. The Cancer SENESCopedia: A delineation of cancer cell senescence

    Authors: , , , , , , , , , , , , , - Cell Reports 2021 cited by 202

  19. Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 385

  20. Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients

    Authors: , , , , , , , , , , - Nature Cancer 2021 cited by 185

  21. Molecular Maps of the Reorganization of Genome-Nuclear Lamina Interactions during Differentiation

    Authors: , , , , , , , , , , , , - Molecular Cell 2010 cited by 1,076

  22. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 137

  23. DNA damage induces p53-independent apoptosis through ribosome stalling

    Authors: , , , , , , , , , , , , , , , , , - Science 2024 cited by 128

  24. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentina Fornerone, Paola Gabaldi, Felix Haglund, Johan Hartman, Peter Horak, Tanja Jutzi, Mary Kasanicki, Simon Kreutzfeldt, Lucian Le Cornet, Rolf Lewensohn, Johan Lindberg, Carlos López, Andreas Lundqvist, Jose‐Ezequiel Martín, Gerrit A. Meijer, Susana Muñoz, Maud Ngo Camus, Claudio Nicotra, Paolo Nucíforo, Petra Oberrauch, Päivi Östling, Laura Pelz, Alejandro Piris‐Giménez, Elena Provenzano, Étienne Rouleau, John Rowell, Omar Saavedra, Giovanni Scoazec, Kenneth B. Seamon, Marc Tischkowitz, Lizet van der Kolk, Ruud van der Noll, María Vieito, Daniël J. Vis, Ana Vivancos, Christina von Gertten, Anders Wennborg, Lodewyk F.A. Wessels, Valtteri Wirta, Judith Balmañà, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E. Voest, Jordi Rodón, Janne Lehtiö - Nature Cancer 2022 cited by 130